Home Peptide Products Pasireotide

research use only

Pasireotide

Cat.No.P1127

Pasireotide (SOM230) is a multi-receptor ligand somatostatin analogue with high binding affinity for somatostatin receptor (SSTR) subtypes sst1,2,3 and sst5. It potently suppresses GH, IGF-I and ACTH secretion, indicating potential efficacy in acromegaly and Cushing’s disease.

Amino-acid Sequence

Pasireotide Amino-acid Sequence

CAS No. 396091-73-9

Sellecks Pasireotide Has Been Cited by 1 Publication

Quality Control

Batch: P112701 DMSO] 100 mg/mL] false] Ethanol] 100 mg/mL] false] Water] Insoluble] false Purity: 99.47%
99.47

Chemical Information & Solubility

Storage (from the date of receipt) 3 years-20°C powder

In vitro
Batch:

DMSO : 100 mg/mL (95.49 mM)；
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble


Molecular Weight Calculator

In Vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Biological Activity

Description Pasireotide (SOM230) is a multi-receptor ligand somatostatin analogue with high binding affinity for somatostatin receptor (SSTR) subtypes sst1,2,3 and sst5. It potently suppresses GH, IGF-I and ACTH secretion, indicating potential efficacy in acromegaly and Cushing’s disease.
Targets/IC50/Ki
SST2

References
  • https://pubmed.ncbi.nlm.nih.gov/12773038/

Product Information

Molecular Formula

C58H66N10O9
Molecular Weight 1047.21
CAS No. 396091-73-9
Appearance White Powder
Peptide Content (by %N) ≥80%
Single Impurity (by HPLC) ≤1.0%
Assay (By Anhydrous, Acetic Acid-free) 95.0~105.0%
MS Consistent
Packing plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement.
Storage
(From the date of receipt)		 3 years-20°C powder
Shipping Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)